株探米国株
英語
エドガーで原本を確認する
0001674910false00016749102025-01-282025-01-28


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________________

FORM 8-K
___________________

CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
 
Date of report (Date of earliest event reported): January 28, 2025
__________________________________
 
VALVOLINE INC.
(Exact name of registrant as specified in its charter)
___________________________________
Kentucky   001-37884   30-0939371
(State or other jurisdiction
of incorporation)
  
(Commission
File Number)
  
(I.R.S. Employer
Identification No.)
 
100 Valvoline Way, Suite 100
Lexington, KY 40509
(Address of Principal Executive Offices)

(859) 357-7777
(Registrant’s telephone number, including area code)
___________________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common stock, par value $0.01 per share VVV New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐


Item 5.07. Submission of Matters to a Vote of Security Holders.

On January 28, 2025, Valvoline Inc. (“Valvoline”) held its Annual Meeting of Shareholders (“2025 Annual Meeting”). At the 2025 Annual Meeting, a total of 119,205,736 shares of Valvoline common stock, representing 93% of the shares outstanding and eligible to vote and constituting a quorum, were represented in person or by valid proxies. The final results for each of the matters submitted to a vote of shareholders at the 2025 Annual Meeting are as follows:

Proposal 1: All of the nominees for director were elected to serve a one-year term until the following annual meeting of Valvoline’s shareholders and until their successors have been duly elected and qualified, by the votes set forth in the table below:

Nominees For Against Abstain Broker Non-Vote
Gerald W. Evans, Jr. 110,953,513 694,863 217,436 7,339,924
Lori A. Flees 111,352,738 332,539 180,535 7,339,924
Richard J. Freeland 110,663,288 998,652 203,872 7,339,924
Carol H. Kruse 111,088,619 594,775 182,418 7,339,924
Vada O. Manager 110,668,434 1,015,543 181,835 7,339,924
Patrick S. Pacious 111,115,577 509,427 240,808 7,339,924
Jennifer L. Slater 111,151,412 533,092 181,308 7,339,924
Charles M. Sonsteby 111,165,618 516,474 183,720 7,339,924
Mary J. Twinem 111,235,231 445,916 184,665 7,339,924

Proposal 2: The appointment of Ernst & Young LLP as Valvoline’s independent registered public accounting firm for fiscal 2025 was ratified by the shareholders by the votes set forth in the table below:

For Against Abstain Broker Non-Vote
118,106,386 937,676 161,674 0

Proposal 3: The non-binding advisory vote that shareholders vote on Valvoline’s executive compensation every year was approved by the shareholders by the votes set forth in the table below:

For Against Abstain Broker Non-Vote
102,295,613 9,218,255 351,944 7,339,924





2


SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
  VALVOLINE INC.
     
Date: January 30, 2025 By: /s/ Julie M. O'Daniel
    Julie M. O'Daniel
    Senior Vice President, Chief Legal Officer and Corporate Secretary













3